Athira

$Athira(ATHA)$ $Safe Pro Group(SPAI)$ 今晚盘前两只都有小利润

$Athira(ATHA)$ 利好 -获得三期乳腺癌药物权益正在进行的ELAINE-3三期临床试验已完成超过50%的招募，预计将在2027年中期获得数据。

$Athira(ATHA)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001957912-25-000008  Act: 34  Size: 17 KB 网页链接

$Athira(ATHA)$ 8-K Current report, items 1.01, 3.02, 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-323692  Act: 34  Size: 27 MB 网页链接

$Athira(ATHA)$ Baselake Partners, LP、Baselake Management, LLC 以及 David Paolella 已联合向美国证券交易委员会（SEC）提交了13G表格，报告其持有 Athira Pharma, Inc. 的197,481股普通股，占已发行股份的5.0%。文件显示这些股份由Baselake Partners, LP持有，其中Baselake Management, LLC担...

$Athira(ATHA)$ 8-K Current report, item 8.01 Accession Number: 0001193125-25-229293  Act: 34  Size: 157 KB 网页链接

$Athira(ATHA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-269544  Act: 34  Size: 10 MB 网页链接

$Athira(ATHA)$ 8-K/A [Amend] Current report, items 1.01, 3.02, 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-323786  Act: 34  Size: 27 MB 网页链接

$Athira(ATHA)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001376474-25-000840  Act: 34  Size: 9 KB 网页链接

$Athira(ATHA)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001193125-25-269506  Act: 34  Size: 393 KB 网页链接